A new drug that combines Actos with an angiotensin receptor blocker called TAK-536 has entered into Phase III clinical trials in the United States, Takeda Pharmaceuticals has reported. The drug is designed to control both glucose levels and hypertension in patients with Type 2 diabetes. Approximately 60 percent of patients in the U.S. who have diabetes also have hypertension.
Read moreThere's a medication called salsalate, which is a nonsteroidal anti-inflammatory drug, and has been used for many years to treat arthritis.... Read more »
The media recently picked up a press release about a "New Drug to Treat Diabetes." Turns out that the FDA has authorized Zydus Cadila, a... Read more »
The dental professional will encounter various oral health problems during the course of treating his or her patients with diabetes. ... Read more »
Traditionally, treatment of type 2 diabetes went something like this: You're diagnosed and told to "watch your sugar," or you're told to... Read more »
Low-carb advocates are already jumping all over the American Diabetes Association for the new "Nutrition Recommendations" that the... Read more »
The rheumatoid arthritis (RA) drug Rituxan may also help people who have recently been diagnosed with Type 1 diabetes, new research suggests. In a... Read more »
A patient with diabetic neuropathy wants to know why it occurs and what drugs can treat the pain. Newspaper columnist Nurse Patti explains that the... Read more »
Scientists at the University of Illinois-Chicago say the diabetes drug Actos may help protect the brains of people who suffer from multiple sclerosis... Read more »
According to researchers, over-the-counter allergy and asthma drugs helped diabetic mice lose weight and control their blood sugar in a recent study.... Read more »
A new drug based on a chemical found in garlic may be effective at treating Type 1 and Type II diabetes, Japanese researchers say. In a study on... Read more »